MXPA03000861A - Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. - Google Patents
Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo.Info
- Publication number
- MXPA03000861A MXPA03000861A MXPA03000861A MXPA03000861A MXPA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- general formula
- dementia
- group
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Medicinas para el tratamiento o la prevencion de demencia, que contienen como ingrediente activo derivados de 2-aril-8-oxodihidropurina de la formula general (I) o sales de adicion acido de los mismos aceptables farmaceuticamente: (I) [en donde W es H, alquilo de C1-6, halogeno, alcoxi de C1-6, o los similares; X es H, alquilo de C1-6, un grupo de la formula general (Q): -CH(R3) CON (R1) (R2) (en donde R1 es alquilo de C1-6 o los similares; R2 es alquilo de C1-4 substituido con fenilo o los similares; y R3 es H o los similares), o los similares; Y es H, alquilo de C1-6, un grupo de la formula general (Q) anterior, o los similares; y A es fenilo substituido o los similares, con la condicion de que uno de X e Y sea un grupo de la formula general (Q) y el otro sea un grupo seleccionado de entre los descritos anteriormente para X e Y excepto los de la formula general (Q))]. Los compuestos anteriores exhiben un efecto mejorador extremadamente potente sobre trastornos del aprendizaje y/o trastornos de la memoria y asi son utiles en el tratamiento o la prevencion de demencia del tipo Alzheimer, demencia cerebrovascular, demencia senil, y asi sucesivamente. (ver formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000230209 | 2000-07-31 | ||
PCT/JP2001/006363 WO2002010167A1 (fr) | 2000-07-31 | 2001-07-24 | Medicaments contre la demence contenant des derives de 2-aryl-8-oxodihydropurine comme ingredient actif |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03000861A true MXPA03000861A (es) | 2004-04-05 |
Family
ID=18723200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03000861A MXPA03000861A (es) | 2000-07-31 | 2001-07-24 | Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6962921B2 (es) |
EP (1) | EP1306378A4 (es) |
KR (1) | KR100829297B1 (es) |
CN (1) | CN1247578C (es) |
AU (1) | AU7278701A (es) |
BR (1) | BR0112881A (es) |
CA (1) | CA2416706C (es) |
CZ (1) | CZ2003234A3 (es) |
HK (1) | HK1054231A1 (es) |
HU (1) | HUP0303714A3 (es) |
IL (1) | IL154049A0 (es) |
MX (1) | MXPA03000861A (es) |
NO (1) | NO20030474L (es) |
NZ (1) | NZ523812A (es) |
PL (1) | PL363870A1 (es) |
RU (1) | RU2277096C2 (es) |
SK (1) | SK1292003A3 (es) |
WO (1) | WO2002010167A1 (es) |
ZA (1) | ZA200300549B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7760101B2 (en) * | 2008-06-20 | 2010-07-20 | Kimberly-Clark Worldwide, Inc. | Method of reducing sensor corrosion in absorbent articles |
EP2476682B1 (en) * | 2009-09-09 | 2017-04-26 | Sumitomo Dainippon Pharma Co., Ltd. | 8-oxodihydropurine derivative |
US20140301947A1 (en) | 2011-06-06 | 2014-10-09 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
CA2112487C (en) * | 1991-06-26 | 2003-04-15 | James W. Young | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
NZ329798A (en) * | 1996-07-03 | 1999-04-29 | Japan Energy Corp | Purine derivatives their tautomers and salts thereof and interferon secretion inducers, antiviral agents and anticancer drugs containing the same |
ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
JP3814125B2 (ja) * | 1999-06-02 | 2006-08-23 | 大日本住友製薬株式会社 | 2−アリール−8−オキソジヒドロプリン誘導体からなる医薬 |
-
2001
- 2001-07-24 PL PL01363870A patent/PL363870A1/xx not_active Application Discontinuation
- 2001-07-24 EP EP01951985A patent/EP1306378A4/en active Pending
- 2001-07-24 KR KR1020037001365A patent/KR100829297B1/ko not_active IP Right Cessation
- 2001-07-24 NZ NZ523812A patent/NZ523812A/en unknown
- 2001-07-24 WO PCT/JP2001/006363 patent/WO2002010167A1/ja active IP Right Grant
- 2001-07-24 US US10/343,453 patent/US6962921B2/en not_active Expired - Fee Related
- 2001-07-24 CZ CZ2003234A patent/CZ2003234A3/cs unknown
- 2001-07-24 CN CNB018163742A patent/CN1247578C/zh not_active Expired - Fee Related
- 2001-07-24 SK SK129-2003A patent/SK1292003A3/sk unknown
- 2001-07-24 HU HU0303714A patent/HUP0303714A3/hu unknown
- 2001-07-24 MX MXPA03000861A patent/MXPA03000861A/es active IP Right Grant
- 2001-07-24 IL IL15404901A patent/IL154049A0/xx unknown
- 2001-07-24 RU RU2003105827/04A patent/RU2277096C2/ru not_active IP Right Cessation
- 2001-07-24 BR BR0112881-7A patent/BR0112881A/pt not_active IP Right Cessation
- 2001-07-24 CA CA002416706A patent/CA2416706C/en not_active Expired - Fee Related
- 2001-07-24 AU AU7278701A patent/AU7278701A/xx not_active Withdrawn
-
2003
- 2003-01-21 ZA ZA200300549A patent/ZA200300549B/en unknown
- 2003-01-30 NO NO20030474A patent/NO20030474L/no not_active Application Discontinuation
- 2003-09-10 HK HK03106435.7A patent/HK1054231A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20030474L (no) | 2003-03-27 |
NO20030474D0 (no) | 2003-01-30 |
AU7278701A (en) | 2002-02-13 |
KR20030019634A (ko) | 2003-03-06 |
EP1306378A1 (en) | 2003-05-02 |
CN1247578C (zh) | 2006-03-29 |
CZ2003234A3 (cs) | 2003-05-14 |
ZA200300549B (en) | 2003-08-19 |
IL154049A0 (en) | 2003-07-31 |
US6962921B2 (en) | 2005-11-08 |
CA2416706C (en) | 2009-04-07 |
WO2002010167A1 (fr) | 2002-02-07 |
EP1306378A4 (en) | 2005-02-09 |
NZ523812A (en) | 2004-07-30 |
HUP0303714A2 (hu) | 2004-03-01 |
CN1466587A (zh) | 2004-01-07 |
RU2277096C2 (ru) | 2006-05-27 |
KR100829297B1 (ko) | 2008-05-13 |
HUP0303714A3 (en) | 2007-03-28 |
US20030166667A1 (en) | 2003-09-04 |
PL363870A1 (en) | 2004-11-29 |
SK1292003A3 (en) | 2003-08-05 |
CA2416706A1 (en) | 2002-02-07 |
BR0112881A (pt) | 2003-07-01 |
HK1054231A1 (zh) | 2003-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04006322A (es) | Derivados de 6-fluorobiciclo[3.1.0]hexano. | |
TW330202B (en) | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals | |
EP1043324A4 (en) | PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT | |
NO950297D0 (no) | Prolinamidderivater | |
WO2001009103A3 (en) | Imidazole antiproliferative agents | |
WO1998035951A3 (en) | New aminopiperazine derivatives | |
EP1182193A4 (en) | REMEDIES FOR NEUROGENIC PAIN | |
WO2002032901A3 (en) | Bridged piperazine derivatives | |
NO20014119D0 (no) | Medikament inneholdende et sulfopyranosylacylglycerolderivat | |
ES2093091T3 (es) | Derivado de glutation. | |
EP0801065A4 (en) | 1,4-DIHYDROPYRIDINE COMPOUNDS AND MEDICAL COMPOSITIONS CONTAINING THEM | |
ATE310010T1 (de) | 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung | |
KR0165901B1 (en) | 4-[(2-BENZOTHIAZOLYL) METHYLAMINO]-Ñß-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINE ETHANOL | |
EP1130015A4 (en) | PYRIDAZINONE DERIVATIVES | |
MXPA03000861A (es) | Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. | |
WO2000044722A8 (fr) | Promoteurs de la chondrogenese et derives d'indolin-2-one | |
EP1219296A4 (en) | SEBUM PRODUCTION INHIBITORS | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
AU2983792A (en) | Diaminomethyleneamino substituted substituted phenyl thiazoles | |
CA2221689A1 (en) | Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions | |
EP1219619A4 (en) | piperidine | |
EP1264829A4 (en) | OXYGEN-CONTAINING HETEROCYCLES | |
EP0657443A4 (en) | OPTICALLY ACTIVE CARBOXAMIDE DERIVATIVES. | |
EP1270561A4 (en) | BRASSINOSTEROIDES BIOSYNTHESIS INHIBITOR | |
EP1157997A4 (en) | NEW DIPEPTIDE COMPOUND AND THEIR MEDICAL APPLICATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status | ||
FG | Grant or registration |